Post by icemandios on Feb 8, 2017 14:13:41 GMT
Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference
BOULDER, Colo., Feb. 8, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Partners Annual Global Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event:
Leerink Partners Annual Global Healthcare Conference
Presenter:
Ron Squarer, Chief Executive Officer
Date:
Wednesday, February 15, 2017
Time:
3:00 p.m. Eastern Time
Webcast:
wsw.com/webcast/leerink28/arry
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).
CONTACT:
Tricia Haugeto
Array BioPharma Inc.
303-386-1193
thaugeto@arraybiopharma.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-leerink-partners-annual-global-healthcare-conference-300403014.html